Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice
Allergologia et Immunopathologia · 2024
DOI: 10.15586/aei.v52i4.1126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2024. Verfasst von Haiyan Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu,…. Hauptthemen laut MEDLINE: Asthma, Airway Remodeling, Diterpenes, Ovalbumin. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Asthma is a widely prevalent chronic disease that brings great suffering to patients and may result in death if it turns severe. Jolkinolide B (JB) is one diterpenoid component separated from the dried roots of Euphorbia fischeriana Steud (Euphorbiaceae), and has anti--inflammatory, antioxidative, and antitumor properties. However, the detailed regulatory role and associated regulatory mechanism in the progression of asthma remain elusive. In this work, it was demonstrated that the extensive infiltration of bronchial inflammatory cells and the thickening of airway wall were observed in ovalbumin (OVA)-induced mice, but these impacts were reversed by JB (10 mg/kg) treatment, indicating that JB relieved the provocative symptoms in OVA-induced asthma mice. In addition, JB can control OVA-triggered lung function and pulmonary resistance. Moreover, JB attenuated OVA-evoked inflammation by lowering the levels of interleukin (IL)-4, IL-5, and IL-13. Besides, the activated nuclear factor kappa B (NF-κB) and transforming growth factor-beta–mothers against decapentaplegic homolog 3 (TGFβ/smad3) pathways in OVA-induced mice are rescued by JB treatment. In conclusion, it was disclosed that JB reduced allergic airway inflammation and airway remodeling in asthmatic mice by modulating the NF-κB and TGFβ/smad3 pathways. This work could offer new opinions on JB for lessening progression of asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
- Department of Pediatric Surgery, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
- Department of Thoracic Surgery, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
- Department of Thoracic Surgery, The Affiliated Huai'an No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China; hayywq@njmu.edu.cn.
Zitieren
APA
Lin, H., Xu, C., Ge, J., Wu, H., & Wang, Q. (2024). Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v52i4.1126
Vancouver
Lin H, Xu C, Ge J, Wu H, Wang Q. Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice. Allergologia et Immunopathologia. 2024. doi:10.15586/aei.v52i4.1126
BibTeX
@article{Lin2024,
author = {Lin, Haiyan and Xu, Chao and Ge, Jintong and Wu, Hua and Wang, Qi},
title = {Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice},
journal = {Allergologia et Immunopathologia},
year = {2024},
doi = {10.15586/aei.v52i4.1126}
}
EUVIMED